SDZ ENS 163

a muscarinic M1 receptor agonist and M2 receptor antagonist

Also Known As:

3-ethyldihydro-4-(1-methyl-1H-imidazol-5-yl)methyl-2(3H)-thiophenone dihydrogen phosphate; ENS 213-163

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Alzheimer Disease (Alzheimer's Disease) 01/01/1993 - "Since SDZ ENS 163 at centrally active doses exerts no peripheral cholinergic effects, it may be useful for the symptomatic treatment of Alzheimer's disease."

1.	Cholinergic Agents (Cholinergics)